DrugPatentWatch Database Preview

Details for Patent: 7,420,057

« Back to Dashboard

Which drugs does patent 7,420,057 protect, and when does it expire?

Patent 7,420,057 protects ADDYI and is included in one NDA.

This patent has thirty-nine patent family members in thirty countries.

Summary for Patent: 7,420,057

Title:	Stable polymorph of flibanserin
Abstract:	The invention relates to the polymorph A of flibanserin, to a technical process for the preparation thereof, as well as to the use thereof for preparing medicaments.
Inventor(s):	Bombarda; Carlo (Chester, VA), Dubini; Enrica (Milan, IT), Ezhaya; Antoine (Milan, IT), Schneider, legal representative; Margarete (Ingelheim, DE), Schneider; Heinrich (Ingelheim, DE)
Assignee:	Boehringer Ingelheim Pharma KG (Ingelheim, DE)
Application Number:	11/546,304
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,420,057
Patent Claim Types: see list of patent claims	Compound; Composition; Process;

Drugs Protected by US Patent 7,420,057

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sprout Pharms	ADDYI	flibanserin	TABLET;ORAL	022526-001	Aug 18, 2015		RX	Yes	Yes			Y	Y

Foreign Priority and PCT Information for Patent: 7,420,057

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	01118593	Aug 2, 2001
	01130180	Dec 19, 2001

International Family Members for US Patent 7,420,057

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	036208
Argentina	077416
Austria	288911
Australia	2002331361
Brazil	0211601